TW227000B - - Google Patents

Info

Publication number
TW227000B
TW227000B TW081100891A TW81100891A TW227000B TW 227000 B TW227000 B TW 227000B TW 081100891 A TW081100891 A TW 081100891A TW 81100891 A TW81100891 A TW 81100891A TW 227000 B TW227000 B TW 227000B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
ring
fused
Prior art date
Application number
TW081100891A
Other languages
English (en)
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW227000B publication Critical patent/TW227000B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
TW081100891A 1991-02-13 1992-02-10 TW227000B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
TW227000B true TW227000B (enExample) 1994-07-21

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081100891A TW227000B (enExample) 1991-02-13 1992-02-10

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531L (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CN101932575B (zh) 2008-01-30 2013-06-12 日本脏器制药株式会社 哌啶衍生物
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP6231484B2 (ja) * 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ,インコーポレイテッド 鼻炎の処置
CN105101965B (zh) 2013-03-15 2021-03-09 安皮奥制药股份有限公司 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ,インコーポレイテッド 関節病態の治療
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
JPH03503889A (ja) * 1988-03-15 1991-08-29 ジー.ディー.サール アンド カンパニー PAF拮抗剤としての1H/3H‐[4‐(N,N‐ジシクロアルキル/分枝アルキルカルボキサミド)‐ベンジル]イミダゾ[4,5‐c]ピリジン類
JP2511550B2 (ja) * 1988-04-28 1996-06-26 シェリング・コーポレーション 融合多環式化合物、組成物、製造方法およびpaf拮抗、抗ヒスタミンおよび/または抗炎症剤としてのその使用
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Also Published As

Publication number Publication date
AU650322B2 (en) 1994-06-16
ATE109482T1 (de) 1994-08-15
AU1168392A (en) 1992-09-15
BR9205615A (pt) 1994-05-17
YU48238B (sh) 1997-08-22
DE69200304T2 (de) 1994-12-08
CZ280504B6 (cs) 1996-02-14
FI933531A7 (fi) 1993-08-10
PL169304B1 (pl) 1996-06-28
FI933531A0 (fi) 1993-08-10
FI933531L (fi) 1993-08-10
CS42592A3 (en) 1992-09-16
US5358953A (en) 1994-10-25
ZA921005B (en) 1993-08-12
HU9302327D0 (en) 1993-10-28
DE69200304D1 (de) 1994-09-08
HU211202A9 (en) 1995-11-28
CA2099381A1 (en) 1992-08-14
ES2059212T3 (es) 1994-11-01
NZ241597A (en) 1993-04-28
MY108437A (en) 1996-09-30
IL100887A (en) 1996-01-19
IE920449A1 (en) 1992-08-12
JP2506541B2 (ja) 1996-06-12
IE65125B1 (en) 1995-10-04
CN1040326C (zh) 1998-10-21
YU14392A (sh) 1994-11-15
EG20085A (en) 1997-05-31
GB9102997D0 (en) 1991-03-27
NO300592B1 (no) 1997-06-23
IL100887A0 (en) 1992-11-15
EP0572425B1 (en) 1994-08-03
EP0572425A1 (en) 1993-12-08
HUT65947A (en) 1994-08-29
MX9200589A (es) 1992-10-01
NO932889D0 (no) 1993-08-13
WO1992014734A1 (en) 1992-09-03
KR970005302B1 (ko) 1997-04-15
DK0572425T3 (da) 1994-09-12
CN1064275A (zh) 1992-09-09
JPH06504992A (ja) 1994-06-09
RU2114845C1 (ru) 1998-07-10
NO932889L (no) 1993-08-13
CA2099381C (en) 1996-07-09

Similar Documents

Publication Publication Date Title
TW227000B (enExample)
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
DK0698001T3 (da) Syntetiske glasfibre
MY110142A (en) Thiazolidinedione derivatives, their production and use
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
MX9300312A (es) Antagonistas benzopiranicos y relacionado de ltb.
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
DE69102762D1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
ATE62131T1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
PH17062A (en) Cephalosporins and pharmaceutical compositions
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
DE69011714D1 (de) Kalziumantagonisten.
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.